Results
160
High-performing small cap companies that haven't yet garnered significant analyst attention, and could lead to superior returns.
160 companies
Kaken Pharmaceutical
Market Cap: JP¥143.3b
Produces, markets, and sells medical products, medical devices, and agrochemicals in Japan and internationally.
4521
JP¥3,785.00
7D
-1.5%
1Y
-1.0%
Hunan Fangsheng Pharmaceutical
Market Cap: CN¥4.6b
Researches, develops, produces, and sells pharmaceutical products in China.
603998
CN¥10.48
7D
-0.5%
1Y
-5.9%
Marksans Pharma
Market Cap: ₹114.2b
Engages in the research, manufacturing, marketing, and sale of pharmaceutical formulations in the United States, North America, Europe, the United Kingdom, Australia, New Zealand, and internationally.
MARKSANS
₹251.95
7D
-3.6%
1Y
61.2%
OSE Immunotherapeutics
Market Cap: €131.4m
A clinical-stage biotechnology company, develops immunotherapies in the areas of immune-oncology and immune-inflammation in France and internationally.
OSE
€5.89
7D
-1.3%
1Y
-25.0%
Shanghai Haoyuan Chemexpress
Market Cap: CN¥9.7b
Researches, develops, and manufactures pharmaceutical intermediates and small molecule drugs.
688131
CN¥46.16
7D
4.7%
1Y
120.7%
Zhejiang Medicine
Market Cap: CN¥14.3b
Manufactures and sells life nutrition and pharmaceutical products in China.
600216
CN¥14.83
7D
-1.7%
1Y
52.4%
Animalcare Group
Market Cap: UK£205.6m
Develops, sells, and distributes licensed veterinary pharmaceuticals, and services for companion and production animals, and equine veterinary markets.
ANCR
UK£2.98
7D
6.4%
1Y
21.1%
Square Pharmaceuticals
Market Cap: ৳179.8b
Manufactures, markets, and sells pharmaceutical products in Bangladesh and internationally.
SQURPHARMA
৳202.80
7D
0.4%
1Y
-0.3%
Black Diamond Therapeutics
Market Cap: US$146.7m
A clinical-stage oncology company, focuses on the discovery and development of MasterKey therapies for patients with genetically defined tumors.
BDTX
US$2.58
7D
17.3%
1Y
-50.3%
Mayinglong Pharmaceutical Group
Market Cap: CN¥12.7b
Engages in the manufacturing and sale of Chinese and Western medicines primarily in China.
600993
CN¥29.40
7D
1.4%
1Y
1.8%
Genfit
Market Cap: €185.3m
A late-stage biopharmaceutical company, discovers and develops drug candidates and diagnostic solutions for metabolic and liver-related diseases.
GNFT
€3.72
7D
-7.5%
1Y
-23.3%
Fine Foods & Pharmaceuticals N.T.M
Market Cap: €180.7m
Fine Foods & Pharmaceuticals N.T.M. S.p.A.
FF
€7.38
7D
0%
1Y
-14.8%
China Shineway Pharmaceutical Group
Market Cap: HK$5.7b
An investment holding company, engages in the research and development, manufacture, and trade of Chinese pharmaceutical products in the People’s Republic of China and Hong Kong.
2877
HK$7.48
7D
-1.8%
1Y
-9.1%
Akums Drugs and Pharmaceuticals
Market Cap: ₹86.4b
Manufactures and sells pharmaceutical products and active pharmaceutical ingredients India and internationally.
AKUMS
₹564.15
7D
-1.3%
1Y
n/a
Caplin Point Laboratories
Market Cap: ₹159.1b
Engages in the development, production, marketing, and export of generic pharmaceutical formulations and branded products in India.
524742
₹2,093.55
7D
-2.7%
1Y
53.3%
ChemoMetec
Market Cap: DKK 9.1b
Engages in the development, production, and sale of analytical equipment for cell counting and analysis the United States, Canada, Europe, and internationally.
CHEMM
DKK 523.00
7D
-0.9%
1Y
57.5%